BPA Call 36C24123A0080-36C24124N0006

Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $3.68 million for chemistry testing services to Veterans Integrated Service Network 1 (VISN 1), an operational unit of the Department of Veterans Affairs. Issued on October 1, 2023, with an ultimate completion date of September 30, 2024, this firm fixed-price contract was awarded without set-aside designation, indicating full and open competition. The contract is issued under the General Services Administration's Critical Analyzers, Laboratory schedule (FSS-66-III), a master contract vehicle that enables the VA to streamline procurement of medical diagnostic equipment and laboratory services. Abbott's Diagnostics Division will provide chemistry analyzers, associated reagents, and related clinical laboratory testing capabilities to support VISN 1's healthcare operations.

This award reflects Abbott Laboratories' established role as a critical supplier of advanced diagnostic and clinical laboratory solutions to the VA healthcare system. VISN 1 encompasses VA medical facilities in the New England region, and this contract enables the network to access Abbott's comprehensive portfolio of automated chemistry testing technologies to support patient care across its facilities. The contract is part of Abbott's broader engagement with multiple VA Integrated Service Networks, where the company maintains significant Blanket Purchase Agreements for chemistry and immunochemistry analyzer systems, reagents, and maintenance services. The firm fixed-price structure and full and open competition designation indicate a standard federal procurement process for these essential clinical laboratory capabilities.